The global tissue expanders market size was valued at around USD 948.6 million in 2016. This can be attributed to an increase in the number of reconstruction surgeries being undertaken. According to the American Society of Plastic Surgeons, around 5.8 million reconstruction procedures were performed in the U.S. in 2014.
Breast reconstruction is considered as one of the top 5 cosmetic surgical procedures in this country since 2006. Some of the reconstruction procedures that utilize tissue expanders are scalp reduction surgery and reconstruction of face, neck, arms, and legs. As a result, an increase in the number of breast reconstruction procedures, as well as other reconstruction surgeries, has led to a rise in demand for tissue expanders.
According to the Breast Cancer Research Foundation (BCRF), breast cancer is considered the most common type of cancer among American women, after skin cancer. BCRF also estimated that in 2015, 231,840 new invasive breast cancer cases were to be identified in women and 2,350 in men. Such a high incidence of breast cancer in the U.S. has resulted in an increase in the number of mastectomy and lumpectomy procedures, which further boosts the demand for tissue expanders. Data from a number of researches show that breast reconstruction after mastectomy has helped women psychologically and has enhanced their quality of life.
An increase in the number of trauma cases and severe road accidents are considered as one of the highest impact-rendering drivers, which leads to a rise in demand for tissue expanders. According to WHO, every year around 10 million people are injured or disabled due to road accidents, which leads to a number of injuries involving head, chest, arms, and legs. Road accidents result in severe scars or deformities that most often require surgical treatment. Thus, the increase in the number of road accidents leads to a rise in the number of cosmetic and reconstructive surgeries.
On the basis of application, breast reconstruction held the largest market share in 2016 and is anticipated to exhibit the fastest growth over the forecast period, which can be attributed to an increase in the number of breast reconstructive surgeries being performed after mastectomy. American Society of Plastic Surgeons estimated that around 20% of women opt for reconstruction surgery after mastectomy.
Forehead skin and scalp reconstruction also generated significant revenue in 2016 due to an increase in the number of these procedures. The need for scalp reduction surgical procedures has increased with a rise in the number of trauma & burn cases and a high prevalence of cicatricial alopecia.
The availability of a number of products used in face and neck reconstruction has also supported the increase in the number of these reconstructive procedures. In addition, tissue expansion surgeries performed in the face and neck region result in lesser complications as compared to other parts of the body.
On the basis of shape, anatomical products dominated the market in 2016 as they tend to provide a greater degree of projection as compared to other expanders. Therefore, women who undergo natural-looking breast reconstruction opt for anatomically shaped expanders.
Round-shaped expanders are projected to exhibit the fastest CAGR over the forecast period due to the fact that these products result in soft, round, and accurately proportioned breasts. For instance, Dermaspan, manufactured by Sientra, Inc., is around or anatomically shaped tissue expander that helps achieve soft breasts with the desired shape.
Rectangular-shaped products are expected to witness significant growth over the forecast period as they are commonly used in reconstruction surgeries involving the neck, face, arms, and legs. These expanders are available as both silicone- and saline-filled expanders. For instance, rectangular tissue expander manufactured by Groupe Sebbin is used for tissue augmentation surgeries.
Crescent-shaped tissue expanders contributed significantly to the global tissue expanders market. These products are used for the reconstruction of the breast as well as other body parts. For instance, ACX manufactured by Sientra, Inc. is used for two-stage reconstruction.
On the basis of end use, in 2016, hospitals generated maximum revenue for the market. This is because a majority of reconstructive surgeries are conducted at hospitals, allowing patients to choose from an array of options to improve their physical appearance, due to which people mostly prefer hospital settings.
Cosmetology clinics are expected to witness lucrative growth over the forecast period due to growing concern in women pertaining to their esthetic appeal, especially after mastectomy. In addition, the expertise offered by cosmetologists are specific and allow patients to evaluate various options that are available for reconstructive surgeries.
Ambulatory surgical centers are also anticipated to grow significantly over the forecast period. According to physicians, overnight admission after a breast tissue expansion surgery is not necessary for all cases. Thus, ambulatory surgical centers are considered as an alternative option where reconstructive surgeries can be performed.
In 2016, North America dominated the tissue expander market with the highest revenue share owing to well-established healthcare infrastructure and growing healthcare expenditure. In addition, according to the American Society of Plastic Surgeons, the highest number of reconstructive surgeries that were performed in the U.S. Increase in prevalence of breast cancer in Canada has also contributed to the large revenue share of this region.
Europe also generated significant revenue for the market in 2016 due to an increase in the number of road accidents in Germany. In addition, cosmetic surgeries in the U.K. are on a rise, which further supports the growth of this regional market.
Asia Pacific region is anticipated to exhibit the fastest growth over the forecast period due to an increase in the number of trauma cases and severe road accidents in India. In addition, China has one of the largest cosmetic industry across the world, with more than 10,000 plastic surgery clinics.
Some of the key players in this market are Mentor Worldwide LLC; PMT Corporation; Allergan; Sientra, Inc.; GROUPE SEBBIN SAS; Guangzhou Wanhe Plastic Materials Co. Ltd; KOKEN CO., LTD.; and Eurosilicone.
Key strategies implemented by these major companies are the development of new products & strategic partnerships and regional expansion. For instance, in 2016, Sientra, Inc. acquired Specialty Surgical Products, Inc. (SSP) with an aim to expand its tissue expander portfolio.
Attribute |
Details |
Base year for estimation |
2016 |
Actual estimates/Historical data |
2014 - 2015 |
Forecast period |
2017 - 2025 |
Market representation |
Revenue in USD million & CAGR from 2017 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America, & MEA |
Country scope |
U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, India, China, India, Brazil, Mexico, South Africa, Saudi Arabia |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
15% free customization scope (equivalent to 5-analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the tissue expanders market on the basis of application, shape, end use, and region:
Application Outlook (Revenue, USD Million; 2014 - 2025)
Breast Reconstruction
Two-stage Breast Reconstruction
Single-stage Breast Reconstruction
Forehead Skin and Scalp Reconstruction
Face & Neck Reconstruction
Others
Shape Outlook (Revenue, USD Million; 2014 - 2025)
Anatomical
Round
Rectangular
Crescent
Others
End-Use Outlook (Revenue, USD Million; 2014 - 2025)
Hospitals
Cosmetology Clinics
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.